RPL8 showed a slightly higher expression level in tumor samples (Figure 1D), and the overall survival outcome of CESC patients with higher RPL8 values was worse than that of the patients with lower RPL8 values (Figure 1E). The gene discussed is RPL8; the disease is neoplasm.